Conclave on Obesity, Nutrition & Collaborative Research in Diabetes & Endocrinology — a premier national symposium bringing together 30+ eminent endocrinologists to redefine metabolic and hormonal care.
CONCORDE 2026 is anchored on three interlinked pillars designed to deliver comprehensive, high-yield insights into modern endocrine and metabolic practice.
Medical nutrition therapy, next-generation incretin pharmacotherapy (GLP-1/GIP agonists), bariatric-metabolic surgery endpoints, and collaborative adiposity biology research.
Pediatric growth velocity and short stature evaluation, thyroid nodule pathology & genetics, pubertal timing disorders, adrenal pathology, and metabolic bone health.
Continuous Glucose Monitoring (CGM) analytics, automated insulin delivery systems, cardiorenal protection in T2D, and precision diabetes therapeutics.
CONCORDE 2026 (Conclave on Obesity, Nutrition & Collaborative Research in Diabetes & Endocrinology) is established to break academic silos and spark dynamic partnerships among healthcare professionals across India.
Scheduled for 29th November 2026 at Hotel Marigold, Hyderabad, CONCORDE brings 30+ eminent endocrinologists together for intensive, evidence-based learning.
The conclave provides an immersive environment for postgraduate trainees, fellows, and practicing clinicians to engage with cutting-edge trial data, participate in case-based discussions, and collaborate on real-world Indian metabolic health research.